Allergy/Imm Medical News about multiple sclerosis; DNA-array evaluation

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation
European Journal of Neurology, 06/24/09

Sellebjerg F et al. - The authors identify IFI27, CCL2 and CXCL10 as sensitive biomarkers for the response to IFN-beta. The expression of these markers adequately reflects bioactivity of IFN-beta as documented by the decreased induction in low NAb-positive patients and the lost induction in patients with moderate/high NAb levels.

<< Previous
Direct Injection of Protamine-protected mRNA: Results of a Phase...

Next >>
Why is effective treatment of asthma so difficult? An integrated...

Early Psychiatric Manifestation in a Patient with Primary Progressive Multiple Sclerosis
Archives of Iranian Medicine, 11/12/09 Relevance Score: 69%

Cochlear implantation in a profoundly deaf patient who also suffers from multiple sclerosis - a case study
Cochlear Implants International, 10/27/09 Relevance Score: 69%

A single-centre, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
Multiple Sclerosis, 10/01/09 Relevance Score: 69%

Regulatory and pro-inflammatory phenotypes of myelin basic protein-autoreactive T cells in multiple sclerosis
International Immunology, 10/14/09 Relevance Score: 68%

Early Drug Treatment May Cut Multiple Sclerosis Risk
MedLinePlus, 10/08/09 Relevance Score: 68%